$1.50
-0.10[-6.25%]
At close: Apr 19
$1.50
0[0.00%]
After Hours: 7:46PM EDT
Checkpoint Therapeutics
(NASDAQ:CKPT)Checkpoint Therapeutics Stock (NASDAQ:CKPT), Analyst Ratings, Price Targets, Predictions
Checkpoint Therapeutics Inc has a consensus price target of $28.57, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., B. Riley Securities, and HC Wainwright & Co. on March 22, 2024, December 20, 2023, and December 19, 2023. With an average price target of $24 between HC Wainwright & Co., B. Riley Securities, and HC Wainwright & Co., there's an implied 1500.00% upside for Checkpoint Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
B. Riley Securities
Lake Street
Cantor Fitzgerald
Ladenburg Thalmann
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Checkpoint Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/22/2024 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 2166.67% | HC Wainwright & Co. | Joseph Pantginis | → $34 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 166.67% | B. Riley Securities | Mayank Mamtani | $8 → $4 | Maintains | Buy | Get Alert |
| 12/19/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 2166.67% | HC Wainwright & Co. | Joseph Pantginis | → $34 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 833.33% | Lake Street | Thomas Flaten | $16 → $14 | Maintains | Buy | Get Alert |
| 08/15/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 833.33% | Cantor Fitzgerald | Jennifer Kim | $19 → $14 | Maintains | Overweight | Get Alert |
| 08/15/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 3033.33% | Ladenburg Thalmann | Jeffrey Cohen | $65 → $47 | Maintains | Buy | Get Alert |
| 08/04/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 2166.67% | HC Wainwright & Co. | Joseph Pantginis | → $34 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 966.67% | Lake Street | Thomas Flaten | $22 → $16 | Maintains | Buy | Get Alert |
| 05/17/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 4233.33% | Ladenburg Thalmann | Jeffrey Cohen | $69 → $65 | Maintains | Buy | Get Alert |
| 05/16/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 1166.67% | Cantor Fitzgerald | Jennifer Kim | $54 → $19 | Maintains | Overweight | Get Alert |
| 04/28/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 2166.67% | HC Wainwright & Co. | Joseph Pantginis | $76 → $34 | Maintains | Buy | Get Alert |
| 04/04/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 1366.67% | Lake Street | Thomas Flaten | $32 → $22 | Maintains | Buy | Get Alert |
| 04/03/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 4500% | Ladenburg Thalmann | — | $96 → $69 | Maintains | Buy | Get Alert |
| 03/02/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 4966.67% | HC Wainwright & Co. | Joseph Pantginis | → $76 | Reiterates | → Buy | Get Alert |
| 01/04/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 900% | Cantor Fitzgerald | Jennifer Kim | → $15 | Maintains | Overweight | Get Alert |
| 12/23/2022 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 4966.67% | HC Wainwright & Co. | Joseph Pantginis | $26 → $76 | Maintains | Buy | Get Alert |
| 12/19/2022 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 900% | B. Riley Securities | Mayank Mamtani | $7 → $15 | Maintains | Buy | Get Alert |
| 01/25/2022 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 1633.33% | HC Wainwright & Co. | Joseph Pantginis | $170 → $260 | Maintains | Buy | Get Alert |
| 06/09/2021 | CKPT | Buy Now | Checkpoint Therapeutics | $1.50 | 1100% | B. Riley Securities | — | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Checkpoint Therapeutics (CKPT)?
The latest price target for Checkpoint Therapeutics (NASDAQ: CKPT) was reported by HC Wainwright & Co. on March 22, 2024. The analyst firm set a price target for $34.00 expecting CKPT to rise to within 12 months (a possible 2166.67% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Checkpoint Therapeutics (CKPT)?
The latest analyst rating for Checkpoint Therapeutics (NASDAQ: CKPT) was provided by HC Wainwright & Co., and Checkpoint Therapeutics reiterated their buy rating.
When was the last upgrade for Checkpoint Therapeutics (CKPT)?
There is no last upgrade for Checkpoint Therapeutics.
When was the last downgrade for Checkpoint Therapeutics (CKPT)?
There is no last downgrade for Checkpoint Therapeutics.
When is the next analyst rating going to be posted or updated for Checkpoint Therapeutics (CKPT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Checkpoint Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Checkpoint Therapeutics was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
Is the Analyst Rating Checkpoint Therapeutics (CKPT) correct?
While ratings are subjective and will change, the latest Checkpoint Therapeutics (CKPT) rating was a reiterated with a price target of $0.00 to $34.00. The current price Checkpoint Therapeutics (CKPT) is trading at is $1.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.